Clinical Trials Logo

Healthy Population clinical trials

View clinical trials related to Healthy Population.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06314685 Active, not recruiting - Healthy Population Clinical Trials

Immunogenicity and Safety of MCV4 in Volunteers Aged 6 Months-5 Years

Start date: December 10, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the immunogenicity and safety of Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in healthy volunteers aged from 3 months to 5 years old.

NCT ID: NCT06314659 Active, not recruiting - Healthy Population Clinical Trials

Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 Months

Start date: September 17, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the immunogenicity and safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in healthy volunteers aged from 3 to 5 months old.

NCT ID: NCT05999916 Active, not recruiting - Clinical trials for Healthy Participants

Evaluate the Safety and Feasibility of tACS With the Miamind Neurostimulator in Healthy Participants

MindStim
Start date: December 27, 2023
Phase: N/A
Study type: Interventional

The present study aims to assess the safety and feasibility of repeated transcranial alternating current stimulation (tACS) by the Miamind Neurostimulator in a cohort of healthy participants. Based on the findings of this investigation, subsequent clinical trials assessing the efficiency of tACS by the Miamind Neurostimulator for treatment of Alzheimer's Disease will be conducted.

NCT ID: NCT05339841 Active, not recruiting - Healthy Population Clinical Trials

Italian Digital Primary Cardiovascular Prevention Study

CV-PREVITAL
Start date: June 10, 2022
Phase: N/A
Study type: Interventional

The CV-PREVITAL study is a randomised clinical trial (RCT) controlled versus usual-care designed to compare the effectiveness of a mobile health (mHealth) intervention with that of usual care in reducing specific cardiovascular (CV) risk factors (in the short term) and the occurrence of vascular events (in the long term). Promoted by the Italian Network of Cardiology (ICN, a cardiovascular research network promoted by the Italian Ministry of Health), in collaboration with the Consorzio Sanità (Co.S., an Italian consortium of general practitioners), CV-PREVITAL aims to develop an innovative model of cardiovascular primary prevention and to validate it in a very large sample of subjects and in 'real life' conditions.